MétaCan
Menu
Back to cohort
Record W2135490124 · doi:10.1016/j.bbmt.2012.11.049

Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated on Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)

2013· article· en· W2135490124 on OpenAlexaff
Joanne Kurtzberg, Shelly L. Carter, Adam Mendizabal, Donna A. Wall, Kirk R. Schultz, Nancy A. Kernan, Mary Eapen, John E. Wagner

Bibliographic record

VenueBiology of Blood and Marrow Transplantation · 2013
Typearticle
Languageen
FieldMedicine
TopicHematopoietic Stem Cell Transplantation
Canadian institutionsBC Children's HospitalCancerCare Manitoba
Fundersnot available
KeywordsMedicineFludarabineInternal medicineGastroenterologyCyclophosphamidePrednisoneCord bloodUmbilical Cord Blood TransplantationTransplantationUmbilical cordSurgeryImmunologyHematopoietic stem cell transplantationChemotherapy

Abstract

fetched live from OpenAlex

We compared overall survival for recipients of a single UCB unit treated for hematological malignancy on the COBLT Study (n=191) conducted from 1999-2004 to BMT CTN 0501 (n=113) conducted from 2006-2012. The BMT CTN 0501 is sponsored by NHLBI and NCI and, COBLT was sponsored by NHLBI. Overall survival at 1-year was the primary endpoint for both trials. Eligibility for both trials was similar with a minimum total nucleated cell dose (TNC) of 2.5x107/kg for BMT CTN and 1x107/kg for COBLT and HLA match of 4/6 at antigen level for HLA A and B and allele level for HLA DRB1. All patients received TBI 1350 cGy and cyclophosphamide 120 mg/kg. Patients enrolled on COBLT also received equine ATG 90 mg/kg and those on BMT CTN 0501 fludarabine 75mg/m2 with GVHD prophylaxis consisting of cyclosporine/methyl prednisone and cyclosporine/mycophenolate mofetil, respectively. The distribution of patient performance scores, diseases, TNC (median dose: 4.8 x 107/kg for BMT CTN 0501 and COBLT, 5. 1 x 107/kg) and CD34 dose of the UCB units were similar. Compared to those on BMT CTN 0501, patients on COBLT were slightly younger (median age: 8 vs. 10 years, p=0.0007), more likely to be in relapse at transplant (16% vs. 5%, p=0.0002) and less likely to receive a 5-6/6 HLA-matched unit (29% vs. 59%, p<0.0001). The 1-year, the probabilities of overall survival were 57% (95% CI 50 – 64) on COBLT and 71% (95% CI 62 – 79) on BMT CTN 0501 (p=0.01). In multivariate analysis, mortality risks were higher for patients enrolled on COBLT compared to those on BMT CTN 0501 (HR 1.82, 95% CI 1.19 – 2.78, p=0.006). Mortality risks were also higher in non-Caucasians independent of clinical trial (HR 1.95, 95% 1.32 – 2.88, p=0.0007). The primary causes of death on both trials were similar except for higher incidence of primary graft failure on COBLT. The most frequent causes of death in both treatment groups were recurrent leukemia and GVHD. In summary, survival was better for patients treated on BMT CTN 0501. Although it is not possible to prove which factor(s) played the greatest role, it is the “package” including conditioning and GVHD prophylactic regimens, supportive care, method of unit selection and transplantation period combined that contributed to the improved survival observed in recipients of a single UCB unit in BMT CTN 0501. Together, these results suggest the BMT CTN 0501 treatment plan represents the new standard by which treatment modifications will be compared.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.046
GPT teacher head0.303
Teacher spread0.257 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueBiology of Blood and Marrow TransplantationSame topicHematopoietic Stem Cell TransplantationFrench-language works237,207